Maxcyte, Inc. financial data

Symbol
MXCT on Nasdaq
Industry
Services-Commercial Physical & Biological Research
Location
9713 Key West Avenue,, Suite 400, Rockville, Maryland
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.34 K % -11.1%
Quick Ratio 78 % +51.5%
Debt-to-equity 14.1 % +8.9%
Return On Equity -15.7 % -30.8%
Return On Assets -13.8 % -29.4%
Operating Margin -108 % -22%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 104 M shares +1.19%
Common Stock, Shares, Outstanding 104 M shares +1.46%
Entity Public Float 468 M USD +14.4%
Common Stock, Value, Issued 1.04 M USD +1.45%
Weighted Average Number of Shares Outstanding, Basic 104 M shares +1.21%
Weighted Average Number of Shares Outstanding, Diluted 103 M shares +1.54%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 44.1 M USD +6.8%
Revenue from Contract with Customer, Excluding Assessed Tax 20.1 M USD -25.1%
Research and Development Expense 24.4 M USD +12.2%
Selling and Marketing Expense 28 M USD +32.8%
General and Administrative Expense 29.7 M USD +11.2%
Operating Income (Loss) -47.4 M USD -30.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9.53 M USD +12.5%
Net Income (Loss) Attributable to Parent -36.6 M USD -20.3%
Earnings Per Share, Basic -0.35 USD/shares -16.7%
Earnings Per Share, Diluted -0.37 USD/shares -60.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 22.2 M USD -41.2%
Accounts Receivable, after Allowance for Credit Loss, Current 5.99 M USD -27.8%
Inventory, Net 12 M USD +16.5%
Assets, Current 179 M USD -27.5%
Property, Plant and Equipment, Net 22.8 M USD -8.59%
Operating Lease, Right-of-Use Asset 11.1 M USD +14%
Other Assets, Noncurrent 295 K USD -26.1%
Assets 258 M USD -8.39%
Accounts Payable, Current 1.67 M USD -52.2%
Liabilities, Current 13.5 M USD -19%
Operating Lease, Liability, Noncurrent 17.8 M USD +12.9%
Other Liabilities, Noncurrent 279 K USD -78.7%
Liabilities 31.6 M USD -6.39%
Retained Earnings (Accumulated Deficit) -185 M USD -24.6%
Stockholders' Equity Attributable to Parent 226 M USD -8.66%
Liabilities and Equity 258 M USD -8.39%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.6 M USD -144%
Net Cash Provided by (Used in) Financing Activities 703 K USD -51.7%
Net Cash Provided by (Used in) Investing Activities -14.4 M USD -149%
Common Stock, Shares Authorized 400 M shares 0%
Common Stock, Shares, Issued 104 M shares +1.46%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -24.3 M USD -191%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 22.2 M USD -41.2%
Deferred Tax Assets, Valuation Allowance 45.6 M USD +38%
Operating Lease, Liability 18.6 M USD +14.7%
Payments to Acquire Property, Plant, and Equipment 804 K USD -48.4%
Lessee, Operating Lease, Liability, to be Paid 27.7 M USD +13.9%
Operating Lease, Liability, Current 825 K USD +73.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.23 M USD +25.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.17 M USD +25.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +15.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.03 M USD +12.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.28 M USD +25.2%
Deferred Tax Assets, Operating Loss Carryforwards 22.5 M USD +0.78%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -8.75 M USD -239%
Preferred Stock, Shares Authorized 5 M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.34 M USD +25.2%
Additional Paid in Capital 411 M USD +3.82%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 4.32 M USD +36.2%
Share-based Payment Arrangement, Expense 13.7 M USD +9.15%
Deferred State and Local Income Tax Expense (Benefit) -3.54 M USD -437%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%